Home/Filings/4/0001209191-21-014497
4//SEC Filing

WATERMAN ROBERT A 4

Accession 0001209191-21-014497

CIK 0000860730other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 7:33 PM ET

Size

15.4 KB

Accession

0001209191-21-014497

Insider Transaction Report

Form 4
Period: 2021-02-24
WATERMAN ROBERT A
SVP & General Counsel
Transactions
  • Sale

    Common Stock

    2021-02-24$178.20/sh13,497$2,405,182339,205 total
  • Sale

    Common Stock

    2021-02-24$176.36/sh43,990$7,758,288282,949 total
  • Sale

    Common Stock

    2021-02-24$175.32/sh4,100$718,809278,849 total
  • Sale

    Common Stock

    2021-02-24$177.00/sh12,266$2,171,056326,939 total
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.75 to $178.695, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.72 to $177.71, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.80 to $176.71, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.00 to $175.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

HCA Healthcare, Inc.

CIK 0000860730

Entity typeother

Related Parties

1
  • filerCIK 0001216856

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 7:33 PM ET
Size
15.4 KB